| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺32.50 |
| 52 Week High | ₺47.66 |
| 52 Week Low | ₺24.34 |
| Beta | 0.56 |
| 1 Month Change | 3.17% |
| 3 Month Change | -15.63% |
| 1 Year Change | 1.56% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 269.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEDTR | TR Medical Equipment | TR Market | |
|---|---|---|---|
| 7D | 2.2% | -0.3% | -3.5% |
| 1Y | 1.6% | -8.7% | 124.3% |
Return vs Industry: MEDTR exceeded the TR Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: MEDTR underperformed the TR Market which returned 124% over the past year.
Price Volatility
| MEDTR volatility | |
|---|---|
| MEDTR Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in TR Market | 11.4% |
| 10% least volatile stocks in TR Market | 5.6% |
Stable Share Price: MEDTR has not had significant price volatility in the past 3 months.
Volatility Over Time: MEDTR's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 728 | n/a | www.meditera.com.tr |
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers breathing sytems products, including breathing circuits, breathing filters, catheter mounts, gas sampling lines, accessories, masks, and connectors. It also provides hospital products, such as barrier cream, surgical hand brushes for skin disinfection, hand and skin antiseptics, and skin and mucosa antiseptics.
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi Fundamentals Summary
| MEDTR fundamental statistics | |
|---|---|
| Market cap | ₺3.87b |
| Earnings (TTM) | ₺25.87m |
| Revenue (TTM) | ₺1.45b |
149.5x
P/E Ratio2.7x
P/S RatioIs MEDTR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDTR income statement (TTM) | |
|---|---|
| Revenue | ₺1.45b |
| Cost of Revenue | ₺832.96m |
| Gross Profit | ₺619.31m |
| Other Expenses | ₺593.44m |
| Earnings | ₺25.87m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.22 |
| Gross Margin | 42.64% |
| Net Profit Margin | 1.78% |
| Debt/Equity Ratio | 5.8% |
How did MEDTR perform over the long term?
See historical performance and comparison